Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient ...

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

Widespread use of maternal RSV vaccination and nirsevimab during the 2024–2025 U.S. RSV season led to a significant reduction ...

By Dr. Priyom Bose, Ph.D.Real-world data from Madrid hospitals show dramatic declines in infant ICU stays, hospital days, and RSV-related admissions after nirsevimab immunization campaign. ...

The infant mortality national rate dropped to about 5.5 infant deaths per 1,000 live births in 2024, according to provisional data from the Centers for Disease Control and Prevention posted Thursday.

TUESDAY, May 6, 2025 (HealthDay News) -- Newborns can be effectively protected against respiratory syncytial virus (RSV) infection through the use of nirsevimab, a monoclonal antibody treatment, ...

The virus causes an infection in the lungs and airways, with most people likely to experience mild to severe cold-like symptoms – 9266 cases of RSV have already been reported in Queensland this ...

A more liberal definition would increase the proportion to 43% of that age group. Although the ACIP work group on RSV adult vaccination is reviewing ... below levels that curtail the spread of the ...

The Department for Health and Social Care expanded access to the life-saving jab this month to prevent these hospitalisations and the 8,000 deaths linked to respiratory syncytial virus (RSV ...